AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

iBio, Inc. Director's Dealing 2025

Feb 24, 2025

35045_dirs_2025-02-24_6ddda5f1-0fe9-440d-8af0-62abb1c66627.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: iBio, Inc. (IBIO)
CIK: 0001420720
Period of Report: 2025-02-21

Reporting Person: Banjak Marc (Chief Legal Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-21	Stock Option (right to buy)	$3.48	A	71000	Acquired	2035-02-20	Common Stock (71000)	Direct

Footnotes

F1: These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc.